Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance

European Journal of Haematology

Volumn 92, Issue 2, 2014, Pages 91-101

  Wawrzyniak, Ewa ^a   Kotkowska, Aleksandra ^b   Blonski, Jerzy Z ^a   Siemieniuk Rys, Monika ^b   Ziolkowska, Ewelina ^a   Giannopoulos, Krzysztof ^c   Robak, Tadeusz ^a   Korycka Wolowiec, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Chromosome banding analysis; Chronic lymphocytic leukemia; Clonal devolution; Clonal evolution; Fluorescence in situ hybridization; IGVH

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE;

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL STUDY; CLONAL EVOLUTION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE DELETION; HUMAN; INTERMETHOD COMPARISON; MALE; METAPHASE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; VERY ELDERLY; YOUNG ADULT;

CHROMOSOME BANDING ANALYSIS; CHRONIC LYMPHOCYTIC LEUKEMIA; CLONAL DEVOLUTION; CLONAL EVOLUTION; FLUORESCENCE IN SITU HYBRIDIZATION; IGVH;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CLONAL EVOLUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; YOUNG ADULT;

EID: 84892674324     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12215     Document Type: Article

References (24)

1. Han T, Ohtaki K, Sadamori N, Block AW, Dadey B, Ozer H, Sandberg AA. Cytogenetic evidence for clonal evolution in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 1986;23:321-8.
2. Juliusson G, Friberg K, Gahrton G. Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia. Cancer 1988;62:500-6.
3. Nowel PC, Moreau L, Growney P, Lambert R. Karyotypic stability in chronic B-cell leukemia. Cancer Genet Cytogenet 1988;33:155-60.
4. Oscier D, Fitchett M, Herbert T, Lambert R. Karyotypic evolution in B-cell chronic lymphocytic leukemia. Genes Chromosom Cancer 1991;3:16-20.
5. Fegan C, Robinson H, Thompson P, Whittaker JA, White D. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia 1995;9:2003-8.
6. Finn WG, Kay NE, Kroft SH, Church S, Peterson LC. Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: a sequential study of karyotypic instability in 51 patients. Am J Hematol 1998;59:223-9.
7. Dicker F, Schnittger S, Haferlach T, Kern W, Schoch C. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IGVH status, and CD38 expression. Blood 2006;108:3153-60.
8. Kotkowska A, Wawrzyniak E, Blonski JZ, Robak T, Korycka-Wolowiec A. Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: comparison with FISH. Leuk Res 2011;35:1032-8.
9. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T. Comprehensive genetic characterization of CLL: a study on 506 cases analyzed with chromosome banding analysis, interphase FISH. IGVH status and immunophenotyping. Leukemia 2007;21:2442-51.
10. Bercova A, Zemanova Z, Trneny M, Schwartz J, Karban J, Cmunt E, Pavlistova L, Brezinowa J, Michalova K. Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization. Neoplasma 2009;56:455-8.
11. Stilgenbauer S, Sander S, Bullinger L, Leupolt E, Winkler D, Krober A, Kienle D, Lichter P, Dohner H. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007;92:1242-5.
12. Loscertales J, Arranz E, Sanz MA, Blas C, Gil-Fernandez JJ, Burgaleta C, Alegre A. Clonal evolution in patients with chronic lymphocytic leukemia. Leuk Lymphoma 2010;51:1142-3.
13. Cavazzini F, Rizzotto L, Sofritti O, et al. Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients. Leuk Lymphoma 2012;53:83-8.
14. Haferlach C, Zenger M, Schnittger S, Kern W, Haferlach T. 17p deletion is the most frequent abnormality acquired during clonal evolution in chronic lymphocytic leukemia (CLL): 429 cases analyzed by interphase FISH and chromosome banding analysis. Blood 2011;118:3870.
15. Janssens A, Van Roy N, Poppe B, Noens L, Philippe J, Speleman F. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature. Eur J Haematol 2012;89:72-80.
16. Shanafelt TD, Witzig TE, Fink SR, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006;24:4634-41.
17. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5546-56.
18. Cheson BD, Bennet JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-7.
19. Shaffer LG, Slovak ML, Campbell LJ, eds. ISCN 2009: An International System for Human Cytogenetic Nomenclature. Basel: Karger; 2009.
20. Shanafelt TD, Hanson C, Dewald GW, Witzig TE, LaPlant B, Abrahamzon J, Jelinek DF, Kay NE. Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression. J Clin Oncol 2008;26:e5-6.
21. Quillette P, Saiya-Cork K, Seymour E, Li C, Shedden K, Malek SN. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia. Clin Cancer Res 2013;19:2893-904.
22. Rossi D, Rasi S, Spina V, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 2013;121:1403-12.
23. Zhang L, Znoyko I, Costa LJ, Conlin LK, Daber RD, Self SE, Wolff DJ. Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia. Cancer Genet 2011;204:654-65.
24. Landau DA, Carter SL, Stojanov P, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013;152:714-26.